Enzyme-Linked Immunosorbent Assay (ELISA) is a biochemical test that detects the presence of antigens (proteins, peptides, and hormones) or antibodies in tissues. In biomedical research and medicine, it is used as an analytical tool and as a diagnostic tool. The ELISA analyzer is used to determine the concentration and presence of analytes in a test sample. In addition to adding reagents and consumables to create the ELISA and displaying the results, the ELISA analyzer can also be used for workflows that are already in place. An automated ELISA analyzer is attached as a screen. Over the forecast period, the ELISA Analyzer market will be driven by the growing number of products designed to make workflows more efficient. Also expected to boost the growth of the ELISA analyzer market during the forecast period are the increasing prevalence of infectious diseases and drug development. New product launches are likely to be hampered by approval, which will in turn limit market growth.
Enzyme-Linked Immunosorbent Assay (ELISA) is a biochemical test that detects the presence of antigens (proteins, peptides, and hormones) or antibodies in tissues. In biomedical research and medicine, it is used as an analytical tool and as a diagnostic tool. The ELISA analyzer is used to determine the concentration and presence of analytes in a test sample. In addition to adding reagents and consumables to create the ELISA and displaying the results, the ELISA analyzer can also be used for workflows that are already in place. An automated ELISA analyzer is attached as a screen. Over the forecast period, the ELISA Analyzer market will be driven by the growing number of products designed to make workflows more efficient. Also expected to boost the growth of the ELISA analyzer market during the forecast period are the increasing prevalence of infectious diseases and drug development. New product launches are likely to be hampered by approval, which will in turn limit market growth.
Coherent Market Insights regional market segmentation includes North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The North American market for ELISA analyzers has a dominant position in the world market due to the increased exposure to infectious diseases, the introduction of diagnostic immunoassays, and the presence of local market participants. For example, according to the US National Survey of Ambulatory Health Care, the US reported approximately 16.8 million doctor visits for infectious and parasitic diseases, but the Asia-Pacific ELISA analyzer market is expected to expand due to increasing demand from emerging economies such as India, where a large patient population demands fast, high throughput technology for the testing and detection of diseases... Read more